PerSys Medical, a global leader in the development and marketing of innovative products for pre-hospital and hospital emergency medical situations, proudly announces today it has received US Food and Drug Administration (FDA) clearance for the NIO Infant.
The NIO Infant is a manual intraosseous (IO) access device that administers intravascular fluids and medications through the proximal tibia as an alternative to IV access during emergency medical situations. Its innovative stepped needle design allows for graduated penetration to the bone marrow cavity. Sensory feedback, in the form of resistance, indicates to the user that the needle is inserted correctly in the bone marrow cavity, thus preventing over penetration. The NIO™ Infant is a single-use, sterile device, eliminating the risk of cross contamination. It does not require batteries or an external power source, thereby making it a well-suited for hospital use, and the pre-hospital setting.
Read the full story.